TechCrunch

DECEMBER 15, 2022

That’s why we weren’t very surprised when a slew of investors told us they rarely see a biotech startup that doesn’t incorporate AI in some form or other these days. But despite becoming quite the buzzword, AI’s apparent ubiquity in biotech isn’t actually driving deal flow or higher valuations.

Biotech 242

Biotech Technical Review Development Team Review Systems Review 242

TechCrunch

MARCH 16, 2023

More posts by this contributor 3 tips for biotech startups seeking non-dilutive capital to weather the downturn Founders in the biotech industry are no strangers to challenges. This is especially true for biotech startups, where investment needs are higher and success timelines can be much longer.

Biotech 231

Biotech Strategy Technical Advisors Marketing 231

TechCrunch

APRIL 6, 2022

But the path won’t be easy: Many biotech companies working with psychedelic compounds must complete multiyear clinical trials that can cost over $100 million before winning FDA approval, similar to any other biotech company. The most important factor that can make or break a psychedelic biotech company is its team.

Biotech 246

Biotech Company Pharmaceuticals Healthcare 246

TechCrunch

DECEMBER 7, 2023

A new Seattle biotech organization will be funded to the tune of $75 million to research “DNA typewriters,” self-monitoring cells that could upend our understanding of biology. The collaboration between the University of Washington, the Chan-Zuckerberg Initiative and the Allen Institute is already underway.

Biotech 235

Biotech Research Organization 235

TechCrunch

OCTOBER 28, 2022

In the world of biotech, for example, it’s extremely capital intensive to develop multiple products that are all going through clinical trials simultaneously. 5 ways biotech startups can mitigate risk to grow sustainably in the long run by Ram Iyer originally published on TechCrunch.

Biotech 242

Biotech Sustainability Programming Healthcare 242

TechCrunch

MARCH 21, 2023

When you think of life sciences and biotech hubs in the U.S., Portal Innovations , a biotech VC firm based in Chicago, is trying to broaden everyone’s horizons and give opportunities to biotech startups growing out of labs in Chicago, Atlanta, and hopefully beyond. As AI pervades biotech, what are investors looking for in 2023?

Biotech 203

Biotech Development Team Review Technical Review Innovation 203

Crunchbase News

DECEMBER 9, 2024

Biotech offerings, while more plentiful, are also running well below prior highs. Below, we pick out winners and losers for venture-backed tech and biotech companies, focusing on large- and medium-sized IPOs. Top biotech performers Biotech companies that debuted on public markets this year also saw plenty of ups and downs.

Biotech 123

Biotech Film Performance Marketing 123

TechCrunch

DECEMBER 16, 2022

6 investors discuss why AI is more than just a buzzword in biotech. In her latest investor survey, Anna Heim spoke to six biotech investors about where AI creates value, short-term market shifts, and how they’d like to be approached by founders: Robert Mittendorff, M.D, general partner and head of healthcare, B Capital.

Case Study 215

Case Study Biotech Survey Study 215

N2Growth Blog

OCTOBER 23, 2023

Understanding the Unique Challenges in Recruiting for Biotech and Life Sciences The recruitment process in the biotech and life sciences industry comes with its own set of unique challenges. One of the primary obstacles is the need for more highly skilled and qualified talent.

Biotech 178

Biotech Strategy Artificial Inteligence Recruiting 178

Crunchbase News

MARCH 4, 2025

Eikon Therapeutics , $351M, biotech: Eikon Therapeutics raised one of the biggest biotech rounds thus far in 2025. The round is the second biggest for a biotech startup this year, behind only London-based Verdiva Bio , a company creating treatments for obesity and cardiometabolic diseases that raised a $411 million Series A in January.

Artificial Inteligence 118

Artificial Inteligence Artificial Intelligence Biotech Lambda 118

Ooda Loop

FEBRUARY 7, 2025

Chinas Ministry of Commerce announced on Tuesday the inclusion of a major US biotech company on its unreliable entity list while stating that the firms discriminatory measures against Chinese enterprises harmed the legitimate rights and interests of Chinese companies.

Biotech 59

Biotech Industry Enterprise Company 59

Ooda Loop

DECEMBER 23, 2024

It was winner-takes-all in biotech investing in 2024. In late April San Francisco-based artificial intelligence drug discovery start-up Xaira announced it had raised $1bn in one […] The post Why bigger is not always better in biotech appeared first on OODAloop. While many companies struggled, dozens raised at least $100mn.

Biotech 59

Biotech Artificial Inteligence Artificial Intelligence Company 59

Ooda Loop

FEBRUARY 28, 2025

a New York-based biotech that went public on Jan. 31 with some fanfare, has a full portfolio of weight-loss drugs in development, using both the hormones already […] The post Why this newly public biotech could become a force in obesity treatments appeared first on OODAloop. Metsera Inc.,

Biotech 59

Biotech Development Company 59

TechCrunch

NOVEMBER 27, 2023

Biotech and AI startup Cradle is finding success with its generative approach to protein design, landing big customers and a hefty $24 million of new investment. Many AI companies in biotech train models […] © 2023 TechCrunch.

Artificial Inteligence 280

Artificial Inteligence Biotech Programming Training 280

TechCrunch

AUGUST 18, 2022

Health span versus life span, longevity for pets versus humans, biotech versus wellness, seniors versus young people, dependency versus autonomy, prevention versus treatment, analytics, education, infrastructure.” He added, “There are multiple angles to solve problems for very heterogeneous groups with different requirements.

Biotech 313

Biotech Survey Groups Healthcare 313

Crunchbase News

NOVEMBER 7, 2024

Those 50 companies that raised large rounds in October ranged across many sectors, including AI, data centers, nuclear energy, biotech, semiconductors, fintech, space and robotics. The second-largest sector, healthcare and biotech, raised around $5.6 Still, AI led But AI was still by far the leading sector, with $12.2

Data Center 131

Data Center Energy Biotech Data 131

CIO

MARCH 4, 2025

Biotechnology and synthetic biology: The swift development of mRNA vaccines in 2020 illustrated biotechs unprecedented speed in delivering transformative products. Many Fortune 500 companies now invest in AI, robotics and biotech startups through corporate venture arms, gaining insights and strategic advantage.

Technology 177

Technology Biotech Artificial Inteligence Artificial Intelligence 177

Ooda Loop

JANUARY 17, 2025

Li had been conducting the competitive research biotech entrepreneurs typically undertake before soliciting investment. Li quickly found […] The post The bar has risen: Chinas biotech gains push US companies to adapt appeared first on OODAloop.

Biotech 59

Biotech Company Research Strategy 59

Crunchbase News

FEBRUARY 19, 2025

We might even see a pickup as more health and biotech startups incorporate AI as a core focus area, given the technologys rapid advancement and increasing sophistication. Even as venture-backed technology offerings have slowed to a crawl, weve continued to see a steady flow of biotech IPOs, including both AI- and non-AI-focused startups.

Healthcare 115

Healthcare Artificial Inteligence Biotech Artificial Intelligence 115

Crunchbase News

NOVEMBER 1, 2024

tied) Kailera Therapeutics , $400M, biotech: Yet another big biotech raise last month, as Kailera Therapeutics announced its launch with a $400 million Series A financing co-led by Atlas Venture , Bain Capital Life Sciences and RTW Investments. Seaport Therapeutics , $225M, biotech: Seaport Therapeutics isn’t new to this list.

Biotech 123

Biotech Energy Artificial Inteligence Artificial Intelligence 123

Ooda Loop

DECEMBER 27, 2024

From the heart of the English commuter town, UK biotech Autolus will process, manufacture and ship to the US a new Car-T cell therapy to treat the blood cancer acute […] The post UK biotech takes on personalised cancer therapy side effects appeared first on OODAloop.

Biotech 59

Biotech Retail Innovation 59

Crunchbase News

JANUARY 13, 2025

Related reading: The Weeks Biggest Funding Rounds: Data Storage And Lots Of Biotech Illustration: Dom Guzman Also last week, Palo Alto, California-based Hippocratic AI , which develops a safety-focused large language model for healthcare, safety and accuracy, raised a $141 million Series B valuing the company at $1.6

Artificial Inteligence 120

Artificial Inteligence Healthcare Biotech Artificial Intelligence 120

TechCrunch

MAY 31, 2022

The appetite for genomic data continues to rise in the field of biotech and pharmaceutical research, but cost is still a factor — even sequencing a full genome now costs as little as $1,000. I asked Almogy what he felt were the areas of the biotech and medical industry that will benefit most from this new capability.

Biotech 315

Biotech Pharmaceuticals Study Artificial Inteligence 315

Crunchbase News

JANUARY 10, 2025

By Caleb Appleton Having invested in the biotech space since before it had a name, Ive seen life sciences investors steer founders toward a therapeutics pipeline in hopes of securing the payout of a winning drug or medical device.

Biotech 115

Biotech Marketing Hardware Industry 115

TechCrunch

OCTOBER 11, 2023

Lyon, France-based precision fermentation startup Bon Vivant, which is using biotech techniques to reprogram yeast microorganisms to produce animal-free milk proteins with a substantially lower environmental footprint than traditional dairy, credits clarity of strategy and execution for keeping its investors enthused at a time when raising remains (..)

Biotech 253

Biotech Strategy 253

Crunchbase News

FEBRUARY 4, 2025

Venture money wasnt concentrated in just one sector, as VCs invested in everything from artificial intelligence to biotech to energy. tied) Retro Biosciences , $1B, biotech: AI can do a lot startup Retro Biosciences thinks it can even help us live longer. billion valuation.

Biotech 125

Biotech Artificial Inteligence Artificial Intelligence Technical Review 125

TechCrunch

OCTOBER 28, 2022

The biotech didn’t specify what roles and departments got trimmed. The Washington- and Lagos-based genomics startup has been considered the showpiece of Africa’s fledging biotech space since it got into Y Combinator in 2019. Yet, 2022 will be a year to forget for the biotech startup.

Biotech 229

Biotech Part-Time VPE Fractional VPE Pharmaceuticals 229

TechCrunch

OCTOBER 28, 2022

Dear Sophie, We have a stealth early-stage biotech startup. Budding Biotech. 5 ways biotech startups can mitigate risk to grow sustainably in the long run. ” In a guest post for TC+, he shares five strategies for biotech startups that are trying to stay warm through the winter ahead.

Technical Review 228

Technical Review Software Review Development Team Review TDD 228

TechCrunch

MARCH 17, 2023

Zero-based budgeting: A proven framework for extending runway 5 strategies for biotech startups to outlast a market downturn Image Credits: Getty Images Spinning up a biotech company is a massive undertaking. “The best founders look for a framework to strategically cut burn while keeping their startup’s value drivers functioning.”

Budget 230

Budget Biotech Artificial Inteligence Banking 230

TechCrunch

FEBRUARY 28, 2023

” Going private: A guide to PE tech acquisitions Biotech proved a surprisingly bright spot in 2022’s startup correction Image Credits: Getty Images The hard science and regulations that govern biotech companies sets them far apart from other startups. biotech deals also set new records in 2022 for both median deal size, $33.5

Biotech 212

Biotech Survey Generative AI Windows 212

Crunchbase News

NOVEMBER 22, 2024

While the Boston startup scene is famous for biotech and deeptech talent, the city has lagged other hubs in creation of ultra-high-valuation AI unicorns. Funding to New Jersey startups, for instance, is already up 37% year over year, thanks mostly to AI cloud infrastructure company CoreWeave , which raised a $1.1 billion Series C in May.

Technical Review 134

Technical Review Artificial Inteligence Biotech Energy 134

Crunchbase News

FEBRUARY 18, 2025

” Marketing AI AI has had a profound effect on many sectors like biotech and cybersecurity, as many startups have added the technology to their platforms. It’s a reimagining of the job of being a marketer.” Marketing is no exception, as Hightouch is only the most recent marketing tech startup to get funding.

Marketing 119

Marketing Artificial Inteligence Artificial Intelligence Biotech 119

TechCrunch

DECEMBER 14, 2023

million and will invest in pre-seed, seed and Series A companies across consumer enterprise, healthcare, financial, biotech and climate. Each fund is $212.5 © 2023 TechCrunch. All rights reserved. For personal use only.

Biotech 224

Biotech Healthcare Enterprise Company 224

TechCrunch

SEPTEMBER 13, 2022

French biotech company WhiteLab Genomics has raised $10 million in funding for an AI platform designed to aid the discovery and development of genomic therapies. How WhiteLab Genomics is using AI to aid gene and cell therapy development by Paul Sawers originally published on TechCrunch.

Biotech 258

Biotech Development Pharmaceuticals Machine Learning 258

TechCrunch

NOVEMBER 30, 2023

The biotech startup's $6.5 million seed round is led by VC firm NFX but it is perhaps equally noteworthy to see that Merck is also participating in the round. © 2023 TechCrunch. All rights reserved. For personal use only.

Biotech 201

Biotech Research 201

Crunchbase News

FEBRUARY 28, 2025

Not surprisingly, those two rounds came from the cybersecurity and biotech industries. Eikon Therapeutics , $351M, biotech: Eikon Therapeutics raised one of the biggest biotech rounds thus far in this young year.

Biotech 78

Biotech Artificial Inteligence Artificial Intelligence Healthcare 78

Crunchbase News

MARCH 3, 2025

lead portfolio companies for this group to go public biotechs Camp4 Therapeutics and BioAge Labs have fared poorly since their fall debuts. In just the past nine quarters 1 , the six firms in our sample have participated as lead investors in more than 600 known funding rounds , per Crunchbase data. Meanwhile, the last U.S.

Biotech 116

Biotech Marketing Company Data 116